The store will not work correctly when cookies are disabled.
3-[(2E)-3,7-Dimethylocta-2,6-dien-1-yl]-2,4,6-trihydroxybenzaldehyde
ID: ALA4278723
PubChem CID: 145980048
Max Phase: Preclinical
Molecular Formula: C17H22O4
Molecular Weight: 290.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)=CCC/C(C)=C/Cc1c(O)cc(O)c(C=O)c1O
Standard InChI: InChI=1S/C17H22O4/c1-11(2)5-4-6-12(3)7-8-13-15(19)9-16(20)14(10-18)17(13)21/h5,7,9-10,19-21H,4,6,8H2,1-3H3/b12-7+
Standard InChI Key: HONUKSJLKVCKJV-KPKJPENVSA-N
Molfile:
RDKit 2D
21 21 0 0 0 0 0 0 0 0999 V2000
13.5747 -10.3309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5747 -11.1565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2902 -11.5713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2902 -12.3968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5747 -12.8075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8592 -12.3968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8592 -11.5713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8592 -9.9202 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.5747 -13.6331 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.0057 -11.1565 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.0057 -12.8075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7170 -12.3968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4325 -12.8075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1480 -12.3968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8635 -12.8075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5790 -12.3968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2945 -12.8075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0101 -12.3968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2945 -13.6331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4325 -13.6331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1390 -11.1565 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
1 8 2 0
5 9 1 0
3 10 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
17 19 1 0
13 20 1 0
4 11 1 0
7 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 290.36 | Molecular Weight (Monoisotopic): 290.1518 | AlogP: 3.85 | #Rotatable Bonds: 6 |
Polar Surface Area: 77.76 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.31 | CX Basic pKa: ┄ | CX LogP: 5.46 | CX LogD: 5.11 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.55 | Np Likeness Score: 2.41 |
References
1. West RA, O'Doherty OG, Askwith T, Atack J, Beswick P, Laverick J, Paradowski M, Pennicott LE, Rao SPS, Williams G, Ward SE.. (2017) African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase., 141 [PMID:29107420] [10.1016/j.ejmech.2017.09.067] |